Biogen (BIIB) Could Be Worth $375-475/Share in a Takeover - RBC Capital's Yee

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. ANET
3. NKE
4. BE
5. PANW
6. CL
7. SNDK
8. TAP
9. DELL
10. ROIV

Go back to Biogen (BIIB) Could Be Worth $375-475/Share in a Takeover - RBC Capital's Yee
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 220.83 --0 (-0%)
Previous Close $220.83    52 Week High $333.65 
Open $220.83    52 Week Low $223.02 
Day High $220.83    P/E 28.28 
Day Low $220.83    EPS $7.81 
Volume 69       

BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 66.53 --0 (-0%)
Previous Close $66.53    52 Week High $108.96 
Open $66.53    52 Week Low $62.12 
Day High $66.53    P/E N/A 
Day Low $66.53    EPS $-1.27 
Volume 205       

Celgene Corp. (NASDAQ: CELG) Delayed: 108.24 --0 (-0%)
Previous Close $108.24    52 Week High $127.00 
Open $7.85    52 Week Low $93.05 
Day High $108.24    P/E 32.12 
Day Low $108.24    EPS $3.37 
Volume 0       

Merck & Co. (NYSE: MRK) Delayed: 150.33 --0 (-0%)
Previous Close $150.33    52 Week High $65.46 
Open $150.33    52 Week Low $47.97 
Day High $150.33    P/E 102.27 
Day Low $150.33    EPS $1.47 
Volume 4,273       

Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Delayed: 546.12 --0 (-0%)
Previous Close $546.12    52 Week High $134.71 
Open $546.12    52 Week Low $73.31 
Day High $546.12    P/E N/A 
Day Low $546.12    EPS $-1.98 
Volume 226